CD4+CD25+ regulatory T cell therapy for the induction of donor-specific clinical transplantation tolerance

Shuiping Jiang, Robert I. Lechler, Xiao Shun He, Jie Fu Huang

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations

Abstract

Naturally occurring CD4+CD25+ regulatory T cells (Tregs) have been shown to play a key role in the control of autoimmunity. Interestingly, they are also capable of mediating transplantation tolerance and they can have indirect allospecificity for donor antigens. An increasing body of evidence in experimental studies has indicated that adoptive transfer of in vitro expanded CD4+CD25+ Tregs with indirect antidonor allospecificity can induce long-term donor-specific transplantation tolerance. Thus, adoptive cell therapy using patient-specific CD4+CD25 + Tregs as individualised medicine to promote clinical transplantation tolerance is promising.

Original languageEnglish (US)
Pages (from-to)1003-1009
Number of pages7
JournalExpert Opinion on Biological Therapy
Volume6
Issue number10
DOIs
StatePublished - Oct 2006

Keywords

  • Adoptive cell therapy
  • CD4CD25 regulatory T cells
  • FoxP3
  • Indirect allospecificity
  • Individualised medicine
  • Transplantation tolerance

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Fingerprint

Dive into the research topics of 'CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cell therapy for the induction of donor-specific clinical transplantation tolerance'. Together they form a unique fingerprint.

Cite this